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Background/aim: Sinonasal polyposis is a complex chronic disease displaying contributions from multiple genetic and environmental
factors. In this study, we analyzed possible genetic factors that increase susceptibility to this widespread inflammatory disease.
Materials and methods: A total of 176 adult patients, including 78 patients with sinonasal polyposis and 98 healthy controls, were
analyzed for IL-1RN VNTR, IL-2(-330), and IL-4 VNTR gene polymorphisms using polymerase chain reaction and enzyme restriction.
Results: IL-1RN and IL-4 VNTR polymorphisms were notably associated with sinonasal polyposis (P = 0.0001 and P = 0.036,
respectively); however, regarding the IL-2(-330) gene polymorphism, no significant difference was shown between the patient and
control groups (P = 0.235).
Conclusions: Our study indicates that the RN2 allele of IL-1RN and the RP1 allele of IL-4 might be risk factors for developing sinonasal
polyposis.
Key words: Nasal polyposis, IL-1RN VNTR, IL-2(-330), IL-4 VNTR, gene polymorphism

1. Introduction
Despite the fact that nasal polyposis was described for the
first time by Hippocrates, its pathogenesis has yet to be
clarified. Nasal polyposis is generally believed to involve a
multitude of genetic and environmental factors; however,
the exact mechanism that starts the ongoing inflammation
is still debated. In the 2012 European Position Paper on
Rhinosinusitis and Nasal Polyps (EPOS) documents, nasal
polyposis was defined as a subgroup of chronic sinusitis
(CRSwNP) [1]. Altered expression levels of cytokines and
chemokines with proinflammatory, antiinflammatory, or
angiogenic features are one of the hypotheses considered
in the etiopathogenesis of sinonasal polyposis.
A number of pro- and antiinflammatory cytokines
are believed to play a role in the inflammatory response
of sinonasal polyposis. Genetic polymorphisms have been
considered important in the definition of the susceptibility
profile for the development of this disease. The IL-1
family is a group of epithelial cytokines including the
potent proinflammatory cytokines IL-1α and IL-1β; their
negative regulator with an antiinflammatory effect is the
IL-1 receptor antagonist (IL-1RN) [2]. The genes encoding

the IL-1 family are located on the long arm of chromosome
2. The IL-1RN gene has a penta-allelic polymorphic site in
the intron 2 region due to the presence of an 86-bp variable
number of a tandem repeat (VNTR) sequence [3,4]. VNTR
may result in genetic variations in an individual and may
further alter the rate of gene transcription, the stability
of mRNA, or the quantity and activity of the encoded
protein. Individuals with different copy numbers of the
repeat sequences differ in the number of potential protein
binding sites, thereby altering the amount of cytokine
production [5]. IL-1RN gene polymorphisms have been
associated with the severity of or susceptibility to various
inflammatory disorders [6].
IL-2 is a lymphokine produced by T cells and plays
a major role in T and B cell cooperation. It induces
the secretion of IL-1, interferon (IFN)-γ, and tumor
necrosis factors (TNF)-α and TNF-β. IL-2 has powerful
immunoregulatory effects on a variety of immune cells
[7]. The gene coding for IL-2 is located on chromosome
4q26-q27 [8]. There is a functional T→G single nucleotide
polymorphism (SNP) at position -330; it has been
suggested that this polymorphism can be useful as a
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marker to diagnose susceptibility to various inflammatory
diseases [9].
IL-4 is a prototypic member of Th2 cytokines and
has potent antiinflammatory features. It reduces the
production and impact of proinflammatory cytokines
and is also involved in the isotype switching from
immunoglobulin (Ig)M/IgG to IgE by B lymphocytes
[10,11]. The IL-4 gene is located on chromosome 5q31–
q33. The IL-4 variable number of tandem repeat (VNTR)
polymorphism is characterized by a rare Rp1 allele (2
repeats = 183 bp), a frequent Rp2 allele (3 repeats = 253
bp), and Rp3 (4 repeats), which is a rarer allele.
In the present study, the association of IL-1RN VNTR,
IL-2(-330), and IL-4 VNTR polymorphisms with sinonasal
polyposis was evaluated.
2. Materials and methods
2.1. Subjects
In this current study, we included 78 patients with nasal
polyposis and 98 healthy controls with no history of nasal
symptoms. The diagnosis of nasal polyposis was made by
anterior rhinoscopy through various nasal endoscopes.
The endoscopic equipment consisted of a series of various
rigid rod lens Hopkins telescopes, a digital one-chip
camera, a Xenon cold light source, and a high-resolution
video monitor screen (all equipment was provided by
Karl Storz Company, Tuttlingen, Germany). Computed
tomography scans were performed to prevent any
misdiagnoses. Patients with Samter’s triad or asthma were
not included in this study. Our research was approved by
the ethics committee of Adana City Education and Research
Hospital. All patients and control subjects were informed
about the study, and their written informed consents were
obtained before commencing the study. Blood samples
were collected in EDTA-coated vials and stored at –20 °C
until required for genomic DNA extraction.
2.2. DNA extraction, oligonucleotide primers, PCR amplification, and restriction digestion
Genomic DNA was isolated from 250 μL of whole blood
from each sample using proteinase K followed by an
E.Z.N.A.® Tissue Kit II (Omega Bio-Tek, Norcross, GA,
USA) in accordance with the manufacturer’s protocol. All
DNA samples were examined at 260/280 nm absorbance
ratio using a PeQLab Nanodrop (Biotechnologie GmbH,
Rheinbreitbach, Germany). PCR amplifications were
performed using 3 primer pairs (Table 1).
Briefly, PCR was performed in a final volume of 25 μL
containing 50 ng genomic DNA template, 10X PCR buffer
with 50 Mm MgCl2, 100–500 nM of each primer, 10 μM
dNTPs, and 5 U DNA polymerase. The DNA was initially
denatured at 94 °C for 5 min prior to amplification. PCR
amplification was accomplished using 35 cycles consisting
of 30 s of denaturation at 94 °C, 45 s of annealing at 50 °C
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Table 1. Three primer pairs for amplification of IL-1RN, IL-2
(-330), and IL-4 gene polymorphisms.
Gene

Primers

IL-1RN

F primer
R primer

5′- ctcagcaacactcctat-3′
5′- tcctggtctgcaggtaa-3′

IL2-330

F primer
R primer

5′- tattcacatgttcagtgtagttct-3′
5′- acattagcccacacttaggt-3′

IL-4

F primer
R primer

5′- aggctgaaagggggaaagc-3′
5′- ctgttcacctcaactgctcc-3′

for IL-1RN, 58 °C for IL-4, and 52 °C for IL2-330 primers,
and 30 s of extension at 72 °C, with a final extension cycle
at 72 °C for 5 min. The PCR fragments of IL-1RA and IL-4
were separated using 1.5% agarose gel electrophoresis.
IL-2-330 (rs2069762) SNP genotyping was performed
using PCR-restriction fragment length polymorphism
(PCR-RFLP). Restriction digestion was performed with
PCR products of IL2-330 in a total volume of 10 μL
amplicons, 2 μL 10X buffer “Tango”, and 10 units of FspBI
(Bfal) enzyme. The samples were then incubated for 16 h
at 37 °C; the digested PCR products were then separated
using 3% agarose gel electrophoresis stained with ethidium
bromide and visualized on a UV transilluminator with
50 base pair DNA ladder and photographed. After FspBI
digestion, the IL2-330 products were separated into 3
fragments (A1, 150bp; A1/A2, 150, 127; and 23bp; A2, 127
and 23bp).
2.3. Statistics
SSPS v. 20 for Windows was applied for the statistical
analysis of this study. The allele frequencies between the
groups were analyzed by using the chi-squared test and
Fisher’s exact test.
3. Results
This present study included a total of 176 subjects, 78
patients with nasal polyposis and 98 healthy controls.
The ages of the nasal polyposis patients ranged from 15
to 80 years (mean: 49 years); 72% of the patient group was
male and 28% was female. The age range of the control
group was between 19 and 78 years (mean: 44 years). In
the control group, 65% were male and 35% were female.
This study genotyped the patient and control groups for
the three polymorphisms.
Genotypes for IL-1RN and IL-4 gene polymorphisms
were analyzed in 78 samples in the study group. The IL1RN allelic distribution showed RN1/RN1, RN1/RN2,
RN1/RN3, RN2/RN2, and RN2/RN4 genotypes, and their
frequencies were 48.7%, 38.46%, 2.56%, 8.97%, and 1.28%,
respectively (Figure 1).
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Figure 1. PCR amplification of genomic DNA analysis for
rs 2234663; SNP of IL-1RN. Lane M: 100-bp DNA marker
(Fermentas); lanes 1, 6, 7: 500-bp and 410-bp amplification
fragments; lane 2: 410-bp amplification fragments; lane 3: 410-bp
and 240-bp amplification fragments; lane 4: 325-bp and 240-bp
amplification fragments; lane 5: 240-bp amplification fragments.

The IL-4 allelic distribution showed RP1/RP1, RP1/
RP2, and RP2/RP2 genotypes, and their frequencies were
5.12%, 26.92%, and 67.94%, respectively for each gene
polymorphism (Figure 2).
Genotypes for IL-2(-330) gene polymorphisms were
analyzed after restriction digestion on 78 samples in the
study group (Figure 3).
The IL-2(-330) allelic distribution showed a
preponderance of the homozygous dominant A1 alleles.
The A1 allele occurred approximately three times more
frequently in the study population than the A2 or mutant
allele. Genotyping showed that the homozygous dominant
genotype (A1A1) was also frequent in the study population,
occurring at a frequency of 33.3%. The frequency of the
heterozygote genotype (A1A2) was 55%; the mutant alleles
(A2A2) were the least frequent, occurring at a frequency of
only 11.66%. Distribution of genotypes frequencies of IL1RA, IL-2 (-330) and IL-4 gene polymorphisms are shown
in Table 2.
4. Discussion
The present research is the first study to evaluate the role of
IL-1RN, IL-2, and IL-4 gene polymorphisms in a Turkish
population with nasal polyposis. Growing evidence
implicates the contribution of genetic and environmental
factors to the pathogenesis of chronic inflammatory
diseases such as sinonasal polyposis. Our study has shown
significantly higher incidence of RN2 and RP1 alleles in
patients. IL-1 and IL-4 seem to play an important role in
the pathogenesis of nasal polyposis because they activate
and mobilize eosinophils and stimulate the differentiation
and growth of B lymphocytes [12].
The IL-1 receptor antagonist gene polymorphism
has been linked with a wide variety of diseases in the
literature. Its association with preeclampsia, psoriasis,

Figure 2. PCR amplification of genomic DNA analysis for rs
8179190; SNP of IL-4. Lane M: 50-bp DNA marker (Promega);
lanes 1–2: 253-bp and 183-bp amplification fragments, lanes
3–4: 253-bp amplification fragment; lane 5: 183-bp amplification
fragment.

Figure 3. PCR-RFLP of genomic DNA analysis for rs 206976;
SNP of IL-2(-330). Lane M: 50-bp DNA marker (Promega); lane
1–3: 150, 127, 23-bp fragments of the IL-2(-330) A1/A2 PCR
product digested with FspBI; lane 4: 127-bp and 23-bp fragments
A2/A2 PCR product digested with FspBI; lane 5: 150-bp and 23bp fragments A1/A1 PCR product digested with FspBI.

asthma, sepsis, inflammatory bowel disease, systemic
lupus erythematosus, gastritis, schizophrenia, intellectual
disability, cervical cancer, and even tonsillar hypertrophy
has been studied recently [13–19]. The correlation
between the IL-1 RN gene polymorphism and asthma has
been demonstrated by various studies from Turkey, Egypt,
South Africa, northern India, and Japan [20–23]. However,
only one study has analyzed its relationship with chronic
rhinosinusitis [24]. In the study of Cheng et al., where
the study population included adult Taiwan-Chinese
patients, they demonstrated that there was significant IL1RN gene polymorphism in patients with CRSsNP, but no
polymorphism in patients with CRSwNP. In our study, we
demonstrated that the IL-1RN VNTR polymorphism was
significantly associated with nasal polyps (P = 0.0001), and
the RN2 allele of IL-1RN was a high risk factor for nasal
polyp formation in the studied Turkish population.
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Table 2. Distribution of genotypes frequencies of IL-1RA, IL-2 (-330), and IL-4 gene
polymorphisms.
Frequency

N (%)

Patients

Controls

rs 2234663

RN1
RN2
RN3
RN4

108 (69.23)
45 (28.84)
2 (1.28)
1 (0.62)

172 (87.75)
21 (10.71)
1 (0.51)
2 (1.02)

0.0001

IL-2-330

rs 206976

A1
A2

95 (60.89)
61 (39.10)

107 (54.59)
89 (45.40)

0.235

IL-4

Rs 8179190

RP1
RP2

29 (18.58)
127 (81.41)

21 (10.71)
175 (89.28)

0.036

Gene
Polymorphism

Reference
SNP ID

Genotyping

IL-1RN

Although it seems as though the findings of Cheng
et al. conflict with those of our study, their study group
only included an Asian population, which is genetically
different from our Turkish study group of Caucasian
origin. Zhang et al. presented the difference of cytokine
patterns of nasal polyposis tissue of Asian patients [25].
In their research, they demonstrated that T(H)2 cytokine
and related marker levels were significantly increased in
the nasal polyposis tissue of white patients, whereas Asian
patients showed a T(H)1/T(H)17 cell pattern, and high
levels of IFN-γ, Th17, and neutrophil-related cytokines
(IL-1β, IL-6, and IL-17).
In this study, we also researched the IL-2(-330) gene
polymorphism of patients with CRSwNP. This gene
polymorphism is linked to many inflammatory and
neoplastic diseases such as basal cell carcinoma, Graves’
disease (IL-2 -330T/G), hepatocellular carcinoma; multiple
sclerosis IL-2 (-330 T/T), Behçet’s disease where the IL-2
(-330 GT) genotype shows susceptibility and the IL-2(-330
T/T) genotype shows a preventive impact, nasopharyngeal
carcinoma IL-2 (-330 T/G), neuroendocrine tumors,
and asthma IL-2 (-330) and IL-2 (+166) [26–33]. The
gene and haplotype profiles of patients with asthma and
chronic obstructive airway disease (COPD) have been
mentioned in a few studies. Trajkov et al. demonstrated
a positive association between patients with COPD and
the IL-2(-330/T:T) genotype and IL-2/TG haplotype, and
a negative association with the IL-2(-330/G:T) genotype
[34]. In contrast, Movahedi et al. reported a positive
correlation with IL-2 GT at position -330 and a negative
correlation with IL-2 TT at position -330 in patients with
asthma [35]. Although the reports were conflicting, they
showed a possible relationship between the IL-2 330
gene polymorphism and inflammatory lung diseases.
Additionally, Hamilos et al. demonstrated that IL-2 mRNA
expression was significantly higher in allergic and aspirin-
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tolerant CRSwNP, and also found that tissue eosinophilia
and T lymphocyte infiltration was not related with IL-2
mRNA expression [36]. We could not find any research
considering the linkage between the IL-2(-330) gene
polymorphism and CRSwNP in the current literature, and
we found no significant relationship between them in our
study.
IL-4, a Th2 cytokine with an antiinflammatory effect, is
one of the most studied cytokines of CRSwNP. The increased
IL-4 level in nasal polyposis has been reported in several
studies [37]. Milonski et al. demonstrated increased IL-4 gene
expression in atopic patients with CRSwNP [38]. Murowicka
et al. showed that the C/T polymorphism of the IL4 gene was
not associated with nasal polyp formation [39]. Zhang et al.
showed that the IL-4 polymorphism of 33T>C and -590C>T
were positively linked with susceptibility to CRS [40].
Park et al. showed that the IL-4 promoter polymorphism
of -590 C/C was linked with the increased expression
of 5-LO in patients with CRSwNP [41]. Yea et al. from
Korea demonstrated that the IL-4 C-590T polymorphism
was protective against nasal polyp formation [42]. In our
study, we searched for IL-4 VNTR gene polymorphisms in
CRSwNP. IL-4 VNTR gene polymorphisms have been the
subject of various studies from Turkey. Their association
with coronary artery disease, knee osteoarthritis, alopecia
areata, diabetic peripheral neuropathy, recurrent aphthous
stomatitis (RAS), multiple sclerosis, and Behçet’s disease in
Turkish population have all been studied previously [43–49].
IL-4 VNTR gene polymorphisms have also been linked with
immune thrombocytopenic purpura (ITP) and asthma in
the current literature [50,51]. In addition, IL-4 and IL-1RN
(VNTR) gene polymorphisms have together been linked to
frailty syndrome and type 2 diabetes mellitus [52,53]. In our
research, we found that IL-4 VNTR polymorphisms were
significantly associated with nasal polyps in the Turkish
population (P = 0.036). Our study shows the effect of the RP1
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allele of IL-4 on the susceptibility of polyposis formation in
patients with CRSwNP.
In conclusion, the etiopathogenesis of sinonasal
polyposis is still an unsolved puzzle of otorhinolaryngology.
The theories that try to enlighten the exact mechanism for
the chronic inflammation become more complex every day.
In this study, we researched possible gene polymorphism
associations and found that the RN2 allele of IL-1RN and

the RP1 allele of IL-4 were high risk factors for developing
sinonasal polyposis in the studied Turkish population. To
our knowledge, this is the first case-control study from
Turkey to analyze the impact of IL-1RN VNTR, IL-2(330), and IL-4 VNTR polymorphisms in the pathogenesis
of sinonasal polyposis. Further studies are needed to
demonstrate the role of these gene polymorphisms in
larger patient groups, as our study group was limited.
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